Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
9.19
-0.34 (-3.57%)
At close: Jun 5, 2025, 4:00 PM
9.19
0.00 (-0.02%)
After-hours: Jun 5, 2025, 7:48 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.39 billion as of June 5, 2025. Its market cap has decreased by -57.39% in one year.
Market Cap
2.39B
Enterprise Value
10.80B
1-Year Change
-57.39%
Ranking
Category
Stock Price
$9.19
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.39B, a decrease of -71.62%. That is a compound annual growth rate of -26.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 2.48B | -35.53% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.38B |
| Johnson & Johnson | 369.72B |
| AbbVie | 331.15B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 268.37B |
| Abbott Laboratories | 233.03B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |